by TractManager | Aug 31, 2021 | Emerging Technology Report
The Vivistim Paired VNS System is an implanted neurostimulator system intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with...
by TractManager | Aug 17, 2021 | Emerging Technology Report
Oportuzumab monatox is an antibody-drug conjugate that targets epithelial cell-adhesion molecule (EpCAM) in development for the treatment of bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer. It is an intravesical treatment, administered through...
by TractManager | Aug 17, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on fecal calprotectin (FC) testing for determining the prognosis of disease activity (i.e., predicting clinical relapse) in patients who are undergoing treatment for ulcerative colitis (UC).Technology Description: Calprotectin...
by TractManager | Aug 17, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on fecal calprotectin (FC) testing to monitor disease activity and guide therapy choices in patients who have ulcerative colitis (UC).Technology Description: Calprotectin is a calcium-binding protein that is abundant in...
by TractManager | Aug 10, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on the use of fecal microbiota transplantation (FMT) to treat adults with ulcerative colitis (UC).Technology Description: FMT is a procedure by which processed stool from healthy donors is infused into a patient’s...
Recent Comments